BIONIK Laboratories to Attend the 2022 American Occupational Therapy Association (AOTA) Conference & Expo

BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to stroke survivors and others with neurological and mobility challenges from hospital to home, today announced its participation in the American Occupational Therapy Association (AOTA) Conference in San Antonio, Texas from March 31 –April 3, 2022. The company will showcase its InMotion technology at booth 801.

The AOTA Conference & Expo brings industry workers and professionals together to explore the latest updates on practice, professional issues, and trends. At this conference, BIONIK will highlight its InMotion robotics ability to deliver intensive therapy to help patients regain motor function following a stroke and other neurological conditions or injuries. BIONIK’s new generation InMotion ARM is an evidence-based neurorehabilitation technology that provides patients with real-time Assistance-as-Needed. The InMotion ARM quietly monitors the patient’s movements during therapy while it gently assists to help complete various motor therapy activities. While conventional therapy will allow physical therapists to complete 30-60 movements per session, BIONIK’s InMotion ARM/HAND device allows clinicians to track up to 1,000 movements per session. InMotion therapy guides the patient through specific tasks, aiming to improve motor control of the arm and hand by increasing strength, range of motion and coordination, and assisting with the provision of efficient, effective, and intensive sensorimotor therapy.

“We look forward to attending AOTA as their mission to advance occupational therapy practices, education and research aligns with BIONIK’s values. Our presence at AOTA gives us the opportunity to connect with our core audience, Occupational Therapists, and showcase how our devices, like the InMotion ARM and ARM/HAND can help achieve the overall goal of improving a patient’s quality of life,” said Richard Russo, Jr., Chief Financial Officer and Interim Chief Executive Office of BIONIK. “Our attendance at this event allows us to share the benefits of our InMotion devices as well as the ongoing training, education and support that we provide for patient results.”